Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shareholder Alert: Lawsuit Alleges Misleading Statements
A shareholder, who purchased shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), filed a lawsuit against Amicus Therapeutics, Inc. in New Jersey over alleged violations of Securities Laws in connection with certain allegedly false and misleading statements.
View full press release